de Vries W A, Becker A E
Int J Cardiol. 1984 Apr;5(4):507-16. doi: 10.1016/0167-5273(84)90086-x.
A pathomorphologic study of 30 hearts of elderly patients, who died during a double-blind trial to assess the long-term effects of oral anticoagulants following myocardial infarction, showed that all patients had suffered of severe and extensive obstructive coronary atherosclerotic disease. Eight hearts were obtained from patients who had received anticoagulants, while 22 hearts were obtained from patients of the placebo group. Complicated coronary arterial lesions, such as cracked plaques and coronary thrombosis, occurred more frequently in hearts of patients of the placebo group. A recurrent recent infarction was found at autopsy in 13 of the 22 patients receiving a placebo, in contrast to 3 of the 8 hearts from the group of patients receiving anticoagulants. The findings point in the same direction as the clinical trial, which showed a statistically significant reduced risk of recurrent myocardial infarction and, hence, cardiac death, but in the autopsy study do not reach statistical significance. The occurrence of grossly recognizable intraventricular thrombosis in 5 of the 22 hearts from the placebo group contrasted to none in the 8 hearts of the anticoagulant group. Although none of these differences is statistically significant they all point in one and the same direction, viz. prevention of complicating thrombotic lesions following the long-term application of anticoagulants.
一项针对30例老年患者心脏的病理形态学研究显示,所有患者均患有严重且广泛的阻塞性冠状动脉粥样硬化疾病。这些患者在一项双盲试验中死亡,该试验旨在评估心肌梗死后口服抗凝剂的长期效果。8颗心脏取自接受抗凝剂治疗的患者,22颗心脏取自安慰剂组患者。安慰剂组患者心脏中复杂的冠状动脉病变,如破裂斑块和冠状动脉血栓形成,更为常见。在接受安慰剂的22例患者中,有13例在尸检时发现近期有复发性梗死,而接受抗凝剂治疗的患者组中,8颗心脏中有3例出现这种情况。这些发现与临床试验结果一致,临床试验显示复发性心肌梗死以及心脏死亡风险在统计学上显著降低,但在尸检研究中未达到统计学意义。安慰剂组22颗心脏中有5颗出现肉眼可见的心室内血栓形成,而抗凝剂组8颗心脏中未出现。尽管这些差异均无统计学意义,但它们都指向同一个方向,即长期应用抗凝剂可预防血栓形成并发症。